Enzon Pharmaceuticals - 2 Year Dividend History | ENZN
Historical dividend payout and yield for Enzon Pharmaceuticals (ENZN) since 2014. The current TTM dividend payout for Enzon Pharmaceuticals (ENZN) as of May 19, 2016 is $0.00. The current dividend yield for Enzon Pharmaceuticals as of May 19, 2016 is 0.00%.
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
Enzon Pharmaceuticals, Inc. is a biotechnology company. It discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company's marketed drug products include PegIntron (R) for chronic hepatitis C; Sylatron (R) for Melanoma; Macugen (R) for neovascular age-related macular degeneration; CIMZIA (R) for Crohn's disease; Oncaspar for acute lymphoblastic leukemia; and Adagen for severe combined immunedeficiency. Enzon Pharmaceuticals, Inc. is headquartered in Piscataway, New Jersey.
|
Stock Name |
Country |
Market Cap |
PE Ratio |